α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy

Medicine & Life Sciences

• cyclodextrin polymer 100%
• Methylprednisolone 59%
• Nanoparticles 47%
• Rheumatoid Arthritis 44%
• Therapeutics 8%
• Polymers 6%
• Animals 5%
• Body Weight Changes 4%
• Experimental Arthritis 4%
• Synovitis 4%
• Buffers 3%
• Half-Life 3%
• Arthritis 3%
• Phosphates 3%
• Kinetics 2%
• Lymphocytes 2%
• In Vitro Techniques 1%

Engineering & Materials Science

• Cyclodextrins 89%
• Nanoparticles 52%
• Polymers 38%
• Animals 14%
• Plasma (human) 9%
• Lymphocytes 7%
• Collagen 6%
• Phosphates 5%
• Swelling 5%
• Derivatives 3%

Chemical Compounds

• Cyclodextrin 51%
• Nanoparticle 26%
• Dose 25%
• Body Weight Change 13%
• Glycinate 9%
• Reaction Half Life 6%
• Phosphate 4%
• Buffer Solution 4%
• Plasma 4%
• Reduction 3%